CD44 and colorectal carcinoma: In accordance with other reports, our survival analysis showed that the reduction in KAI1/CD82 expression [24] and increasing CD44 [5, 28], MMP7 [30, 31], β-catenin [19] expression are indicators of a poor prognosis in CRC patients (Fig. 2).